SGRY (Surgery Partners) 5-Year EBITDA Growth Rate : -10.60% (As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Surgery Partners 5-Year EBITDA Growth Rate?

Surgery Partners's EBITDA per Share for the three months ended in Dec. 2024 was $1.28.

During the past 12 months, Surgery Partners's average EBITDA Per Share Growth Rate was 12.00% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -10.50% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -10.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Surgery Partners was 49.20% per year. The lowest was -14.60% per year. And the median was 6.05% per year.

Competitive Comparison of Surgery Partners's 5-Year EBITDA Growth Rate

For the Medical Care Facilities subindustry, Surgery Partners's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Surgery Partners's 5-Year EBITDA Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Surgery Partners's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Surgery Partners's 5-Year EBITDA Growth Rate falls into.

Save Embed

;

Save Embed

;

Surgery Partners 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Surgery Partners (NAS:SGRY) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Surgery Partners 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Surgery Partners's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Surgery Partners Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Surgery Partners Inc (NAS:SGRY) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

1SP:Germany

Address

340 Seven Springs Way, Suite 600, Brentwood, TN, USA, 37027

Website

https://www.surgerypartners.com

Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earns revenues from contracts with patients in which the performance obligations are to provide health care services.

Executives

Danielle Burkhalter	officer: Chief Human Resources Officer	310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
Jennifer Baldock	officer: Sr. VP, Gen Couns. & Sec.	310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
Harrison R. Bane	officer: American Group President	310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
Marissa Brittenham	officer: Chief Strategy Officer	310 SEVEN SPRINGS WAY, BRENTWOOD TN 37027
David T Doherty	officer: Chief Financial Officer	310 SEVEN SPRINGS WAY, BRENTWOOD TN 37027
Jason Eric Evans	officer: EVP & Chief Operating Officer	310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
Bradley R. Owens	officer: National Group President	310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
Anthony Taparo	officer: President, Atlantic Group	310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
Bain Capital Investors Llc	director, 10 percent owner	200 CLARENDON STREET, BOSTON MA 02116
T. Devin O'reilly	director, 10 percent owner	C/O BAIN CAPITAL PRIVATE EQUITY, LP, 200 CLARENDON STREET, BOSTON MA 02149
Blair E Hendrix	director, 10 percent owner
Andrew T. Kaplan	director	C/O BAIN CAPITAL PRIVATE EQUITY, LP, 200 CLARENDON STREET, BOSTON MA 02116
Wayne S Deveydt	director, officer: Chief Executive Officer	120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
Bain Capital Partners Xi, L.p.	director, 10 percent owner	200 CLARENDON STREET, BOSTON MA 02116
Bain Capital Fund Xi, L.p.	director, 10 percent owner	JOHN HANCOCK TOWER, 200 CLARENDON STREET, BOSTON MA 02116